Abstract
The endocrine system regulates hormones that influence bone metabolism; disruption of this balance can lead to various skeletal disorders. Radiological techniques such as conventional radiography, dual-energy X-ray absorptiometry, computed tomography, and magnetic resonance imaging play a key role in the diagnosis and assessment of these conditions.
Keywords: Diabetes mellitus, osteoporosis, hyperparathyroidism, brown tumor, acromegaly, gigantism, Cushing’s disease, pheochromocytoma, Addison’s disease
References
Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL, et al. Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol. 2017; 13: 208-19.
Napoli N, Schwartz AV, Black DM, for the Osteoporotic Fractures in Men (MrOS) Study Research Group. Reply to: indications of increased vertebral fracture risk in patients with type 2 diabetes. Journal of Bone and Mineral Research. 2018; 33: 183.
Napoli N, Strotmeyer ES, Ensrud KE, Sellmeyer DE, Bauer DC, Hoffman AR, et al. Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014; 57: 2057-65.
Sheu A, White CP, Center JR. Bone metabolism in diabetes: a clinician’s guide to understanding the bone-glucose interplay. Diabetologia. 2024; 67: 1493-506.
Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol. 2003; 17: 945-70.
Picke AK, Campbell G, Napoli N, Hofbauer LC, Rauner M. Update on the impact of type 2 diabetes mellitus on bone metabolism and material properties. Endocr Connect. 2019; 8: R55-R70.
Mader R, Verlaan JJ, Buskila D. Diffuse idiopathic skeletal hyperostosis: clinical features and pathogenic mechanisms. Nat Rev Rheumatol. 2013; 9: 741-50.
Littlejohn GO, Smythe HA. Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol. 1981; 8: 965-8.
Mueller MB, Blunk T, Appel B, Maschke A, Goepferich A, Zellner J, et al. Insulin is essential for in vitro chondrogenesis of mesenchymal progenitor cells and influences chondrogenesis in a dose-dependent manner. Int Orthop. 2013; 37: 153-8.
Belanger TA, Rowe DE. Diffuse idiopathic skeletal hyperostosis: musculoskeletal manifestations. J Am Acad Orthop Surg. 2001; 9: 258-67.
Resnick D, Niwayama G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology. 1976; 119: 559-68.
Clavaguera T, Reyner P, Buxó M, Valls M, Armengol E, Juanola X. Identifying clinicoradiological phenotypes in diffuse idiopathic skeletal hyperostosis: a cross-sectional study. Medicina (Kaunas). 2021; 57: 1005.
Mautone M, Naidoo P. What the radiologist needs to know about Charcot foot. J Med Imaging Radiat Oncol. 2015; 59: 395-402.
Jones EA, Manaster BJ, May DA, Disler DG. Neuropathic osteoarthropathy: diagnostic dilemmas and differential diagnosis. Radiographics. 2000; 20 Spec No: 279-93.
Ahmadi ME, Morrison WB, Carrino JA, Schweitzer ME, Raikin SM, Ledermann HP. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics. Radiology. 2006; 238: 622-31.
Bassett JH, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016; 37: 135-87.
Rivkees SA, Bode HH, Crawford JD. Long-term growth in juvenile acquired hypothyroidism: the failure to achieve normal adult stature. N Engl J Med. 1988; 318: 599-602.
Eriksen EF, Mosekilde L, Melsen F. Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle. Bone. 1986; 7: 101-8.
Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am. 1990; 19: 35-63.
Segni M, Gorman CA. The aftermath of childhood hyperthyroidism. J Pediatr Endocrinol Metab. 2001; 14 Suppl 5: 1277-82; discussion 1297-8.
Rasmussen SA, Yazdy MM, Carmichael SL, Jamieson DJ, Canfield MA, Honein MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol. 2007; 110(2 Pt 1): 369-77.
Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015; 313: 2055-65.
Patel KV, Brennan KL, Brennan ML, Jupiter DC, Shar A, Davis ML. Association of a modified frailty index with mortality after femoral neck fracture in patients aged 60 years and older. Clin Orthop Relat Res. 2014; 472: 1010ve -7.
Younes NA, Shafagoj Y, Khatib F, Ababneh M. Laboratory screening for hyperparathyroidism. Clin Chim Acta. 2005; 353: 1-12.
Broos WAM, Wondergem M, Knol RJJ, van der Zant FM. Parathyroid imaging with 18 F-fluorocholine PET/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res. 2019; 9: 72.
Zhang R, Zhang Z, Huang P, Li Z, Hu R, Zhang J, et al. Diagnostic performance of ultrasonography, dual-phase 99mTc-MIBI scintigraphy, early and delayed 99mTc-MIBI SPECT/CT in preoperative parathyroid gland localization in secondary hyperparathyroidism. BMC Med Imaging. 2020; 20: 91.
Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021; 48: 2801-22.
Chang CY, Rosenthal DI, Mitchell DM, Handa A, Kattapuram SV, Huang AJ. Imaging findings of metabolic bone disease. Radiographics. 2016; 36: 1871-87.
Solmaz B, Tatarlı N, Günver F, Emre T. A thoracic vertebral brown tumor presenting with paraparesis in a patient with end-stage renal disease. Br J Neurosurg. 2017; 31: 635-7.
Khalatbari MR, Moharamzad Y. Brown tumor of the spine in patients with primary hyperparathyroidism. Spine (Phila Pa 1976). 2014; 39: E1073-9.
Hong WS, Sung MS, Chun KA, Kim JY, Park SW, Lee KH, et al. Emphasis on the MR imaging findings of brown tumor: a report of five cases. Skeletal Radiol. 2011; 40: 205-13.
Vaishya R, Agarwal AK, Singh H, Vijay V. Multiple 'brown tumors' masquerading as metastatic bone disease. Cureus. 2015; 7: e431.
Fargen KM, Lin CS, Jeung JA, Yachnis AT, Jacob RP, Velat GJ. Vertebral brown tumors causing neurologic compromise. World Neurosurg. 2013; 79: 208.e1-6.
Knowles NG, Smith DL, Outwater EK. MRI diagnosis of brown tumor based on magnetic susceptibility. J Magn Reson Imaging. 2008; 28: 759-61.
Yang Q, Sun P, Li J, Yang Z, Li X, Li Z, et al. Skeletal lesions in primary hyperparathyroidism. Am J Med Sci. 2015; 349: 321-7.
Gomez CK, Schiffman SR, Bhatt AA. Radiological review of skull lesions. Insights Imaging. 2018; 9: 857-82.
Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016; 2: 16033.
Wittenberg A. The rugger jersey spine sign. Radiology. 2004; 230: 491-2.
Melmed S. Medical progress: acromegaly. N Engl J Med. 2006; 355: 2558-73. Erratum in: N Engl J Med. 2007; 356: 879.
Kerslake R. Diagnosis of Bone and Joint Disorders (4 th edn) 5 Volume Set. Edited by D Resnick, pp. xx+4944, 2002 (WB Saunders Co. Ltd, Philadelphia, PA), £590 ISBN 0721689213. British Journal of Radiology. 2003; 76: 144.
Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004; 25: 102-52.
Killinger Z, Kužma M, Sterančáková L, Payer J. Osteoarticular changes in acromegaly. Int J Endocrinol. 2012; 2012: 839282.
Tagliafico A, Resmini E, Ferone D, Martinoli C. Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiol Med. 2011; 116: 781-92. English, Polish.
De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A. Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab. 2006; 91: 1779-84.
Godang K, Ueland T, Bollerslev J. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing’s syndrome. Eur J Endocrinol. 1999; 141: 126-31.
Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf). 2007; 66: 607-18.
Petramala L, Zinnamosca L, Settevendemmie A, Marinelli C, Nardi M, Concistrè A, et al. Bone and mineral metabolism in patients with primary aldosteronism. Int J Endocrinol. 2014; 2014: 836529.
Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, et al Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn’s Registry. Eur J Endocrinol. 2015; 173: 665-75.
Notsu M, Yamauchi M, Yamamoto M, Nawata K, Sugimoto T. Primary aldosteronism as a risk factor for vertebral fracture. J Clin Endocrinol Metab. 2017; 102: 1237-43.
Ceccoli L, Ronconi V, Giovannini L, Marcheggiani M, Turchi F, Boscaro M, et al. Bone health and aldosterone excess. Osteoporos Int. 2013; 24: 2801-7.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005; 366: 665-75.
Kim BJ, Kwak MK, Kim JS, Lee SH, Koh JM. Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma. Bone. 2018; 116: 1-7.
Kim BJ, Kwak MK, Ahn SH, Kim H, Lee SH, Song KH, et al. Lower bone mass and higher bone resorption in pheochromocytoma: importance of sympathetic activity on human bone. J Clin Endocrinol Metab. 2017; 102: 2711-8.
Antinozzi C, Marampon F, Corinaldesi C, Vicini E, Sgrò P, Vannelli GB, et al. Testosterone insulin-like effects: an in vitro study on the short-term metabolic effects of testosterone in human skeletal muscle cells. J Endocrinol Invest. 2017; 40: 1133-43.
Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002; 23: 279-302.
Wang C, Swerdloff RS. Testosterone replacement therapy in hypogonadal men. Endocrinol Metab Clin North Am. 2022; 51: 77-98.
Arboleya L, Braña I, Pardo E, Loredo M, Queiro R. Osteomalacia in adults: a practical insight for clinicians. J Clin Med. 2023; 12: 2714.
Kanberoglu K, Kantarci F, Cebi D, Yilmaz MH, Kurugoglu S, Bilici A, et al. Magnetic resonance imaging in osteomalacic insufficiency fractures of the pelvis. Clin Radiol. 2005; 60: 105-11.
Rizzoli R, Biver E, Brennan-Speranza TC. Nutritional intake and bone health. Lancet Diabetes Endocrinol. 2021; 9: 606-21.
